Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
The Lancet Oncology(2023)
摘要
Zymeworks, Jazz, and BeiGene.
更多查看译文
关键词
metastatic biliary tract cancer,herizon-btc,single-arm
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要